{"id":"W2131078277","doi":"10.1177/1352458512436594","title":"Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University of Ottawa; Research Canada; McGill University; University of British Columbia","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo; Sanofi","keywords":"Teriflunomide; Medicine; Adverse effect; Discontinuation; Internal medicine; Placebo; Multiple sclerosis; Asymptomatic; Population; Interim analysis; Gastroenterology; Surgery; Randomized controlled trial; Fingolimod; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005114561,0.0008177407,0.002604865,0.0003797154,0.0007731192,0.0007391055,0.0004987317,0.001134661,0.001724076],"category_scores_gemma":[0.002822436,0.0004300036,0.001322944,0.0003406542,0.0005074866,0.0009517078,0.0004195601,0.002161976,0.0006505588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000456528,"about_ca_system_score_gemma":0.000631573,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004265735,"about_ca_topic_score_gemma":0.0007001644,"domain_scores_codex":[0.9990746,0.0003462669,0.0000888119,0.000146626,0.0001637978,0.0001798524],"domain_scores_gemma":[0.9968286,0.0005659364,0.001011214,0.0003449994,0.0003677649,0.0008813686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.607415,0.03202645,0.1401247,0.0007581846,0.003593567,0.001140968,0.0006732809,0.001652824,0.04122263,0.00009484506,0.00309817,0.1681995],"study_design_scores_gemma":[0.08303943,0.4987408,0.3986204,0.0001132196,0.004040251,0.001099765,0.0001546251,0.001395725,0.00830929,0.0001846997,0.004219751,0.00008199727],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955798,0.002429773,0.0003202114,0.0001391469,0.00004673571,0.0003124506,0.0005373262,0.00003593255,0.0005986309],"genre_scores_gemma":[0.9949039,0.0006655848,0.0004928991,0.0003587764,0.0001151737,0.0004279007,0.001995527,0.00001315481,0.001027054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005114561,"threshold_uncertainty_score":0.02704871,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1454125951690546,"score_gpt":0.3555126556853214,"score_spread":0.2101000605162668,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}